Méndez-Vidal Cristina, Bravo-Gil Nereida, González-Del Pozo María, Vela-Boza Alicia, Dopazo Joaquín, Borrego Salud, Antiñolo Guillermo
Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Avenida Manuel Siurot s/n, 41013, Seville, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Seville, Spain.
BMC Genet. 2014 Dec 14;15:143. doi: 10.1186/s12863-014-0143-2.
Molecular diagnosis of Inherited Retinal Dystrophies (IRD) has long been challenging due to the extensive clinical and genetic heterogeneity present in this group of disorders. Here, we describe the clinical application of an integrated next-generation sequencing approach to determine the underlying genetic defects in a Spanish family with a provisional clinical diagnosis of autosomal recessive Retinitis Pigmentosa (arRP).
Exome sequencing of the index patient resulted in the identification of the homozygous BBS1 p.M390R mutation. Sanger sequencing of additional members of the family showed lack of co-segregation of the p.M390R variant in some individuals. Clinical reanalysis indicated co-ocurrence of two different phenotypes in the same family: Bardet-Biedl syndrome in the individual harboring the BBS1 mutation and non-syndromic arRP in extended family members. To identify possible causative mutations underlying arRP, we conducted disease-targeted gene sequencing using a panel of 26 IRD genes. The in-house custom panel was validated using 18 DNA samples known to harbor mutations in relevant genes. All variants were redetected, indicating a high mutation detection rate. This approach allowed the identification of two novel heterozygous null mutations in RP1 (c.4582_4585delATCA; p.I1528Vfs10 and c.5962dupA; p.I1988Nfs3) which co-segregated with the disease in arRP patients. Additionally, a mutational screening in 96 patients of our cohort with genetically unresolved IRD revealed the presence of the c.5962dupA mutation in one unrelated family.
The combination of molecular findings for RP1 and BBS1 genes through exome and gene panel sequencing enabled us to explain the co-existence of two different retinal phenotypes in a family. The identification of two novel variants in RP1 suggests that the use of panels containing the prevalent genes of a particular population, together with an optimized data analysis pipeline, is an efficient and cost-effective approach that can be reliably implemented into the routine diagnostic process of diverse inherited retinal disorders. Moreover, the identification of these novel variants in two unrelated families supports the relatively high prevalence of RP1 mutations in Spanish population and the role of private mutations for commonly mutated genes, while extending the mutational spectrum of RP1.
由于遗传性视网膜营养不良(IRD)存在广泛的临床和遗传异质性,其分子诊断长期以来一直具有挑战性。在此,我们描述了一种综合的下一代测序方法在临床中的应用,以确定一个临床初步诊断为常染色体隐性遗传性视网膜色素变性(arRP)的西班牙家庭的潜在遗传缺陷。
对先证者进行外显子组测序,发现了纯合的BBS1 p.M390R突变。对该家庭其他成员进行的桑格测序显示,在一些个体中p.M390R变异不存在共分离现象。临床重新分析表明,同一家庭中同时出现了两种不同的表型:携带BBS1突变的个体患有巴德-比德尔综合征,而家族其他成员患有非综合征性arRP。为了确定arRP潜在的致病突变,我们使用包含26个IRD基因的基因panel进行了疾病靶向基因测序。使用18个已知在相关基因中存在突变的DNA样本对自制的定制panel进行了验证。所有变异均被重新检测到,表明突变检测率很高。这种方法使得我们在arRP患者中鉴定出了RP1基因中的两个新的杂合无义突变(c.4582_4585delATCA;p.I1528Vfs10和c.5962dupA;p.I1988Nfs3),它们与疾病共分离。此外,在我们队列中96例基因未明确的IRD患者中进行的突变筛查发现,在一个无关家庭中存在c.5962dupA突变。
通过外显子组和基因panel测序对RP1和BBS1基因的分子研究结果相结合,使我们能够解释一个家庭中两种不同视网膜表型的共存现象。在RP1中鉴定出两个新的变异表明,使用包含特定人群中常见基因的panel,再结合优化的数据分析流程,是一种高效且具有成本效益的方法,可可靠地应用于各种遗传性视网膜疾病的常规诊断过程。此外,在两个无关家庭中鉴定出这些新变异,支持了RP1突变在西班牙人群中相对较高的发生率以及私人突变在常见突变基因中的作用,同时扩展了RP1的突变谱。